SBIR 246 - Integrating Patient-Reported Outcomes in Hospice and Palliative
SBIR 246 - Integrating Patient-Reported Outcomes in Hospice and Palliative
批准号:
7698293
负责人:
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-30 至 2009-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our long-term objective is to develop a computer system facilitating the use of patient-reported outcomes (PRO) information to monitor patient status and assist clinical decision making for cancer patients under palliative and hospice care. This system will integrate PRO and other clinical data with evidence-based treatment guidelines and pathways to care and interface with and foster collaborative decision making between the patient, caregivers, and the medical care team. This project will leverage the Adapteval architecture for PRO management developed in our other SBIR efforts, already implementing CAT/IRT capability, multiple delivery platforms, graphical reports highlighting clinically meaningful PRO score changes, alert/reminder mechanisms, and CCOW-compliant integration. Considering the project goals and our past and current R&D efforts, we define the specific Phase I technical objectives as follows: 1) define a palliative/hospice care model to integrate PRO assessment results with evidence-based pathways to provide clinical decision support for clinicians and education opportunities for patients and caregivers via literature review, focus groups, and interviews; 2) design a system architecture facilitating the sharing the transfer of PRO-related medical data between cancer clinics, hospices, and patients' homes; 3) develop a working prototype following object-oriented and knowledge-based software development methodologies; and 4) evaluate the usability and usefulness of the prototype solution via controlled pilot tests. It is expected that Phase I results will validate the feasibility of the proposed solution from the perspectives of both practicality and technology for the purpose of Phase II execution and ultimate commercialization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
APR-246在遗传性TP53相关肿瘤综合征的预防性应用与机制研究
-
批准号:82303579
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚璇
-
依托单位:
基于PDX模型的lncRNA SLCO4A1-AS1通过调控铁死亡介导高级别浆液性卵巢癌对APR-246的耐药及机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:孙成功
-
依托单位:
APR-246通过调控ATF3诱导肉瘤铁死亡的作用与机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王丽嫄
-
依托单位:
靶向药物APR-246对不同TP53基因型弥漫大B细胞淋巴瘤铁死亡的影响及其机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘霞
-
依托单位:
超保守非编码RNAuc.246促进乳腺癌侵袭转移的作用及机制研究
-
批准号:82003116
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:夏文飞
-
依托单位:
Src在Y246磷酸化BCAA分解代谢的限速酶BCKDK,促进结直肠癌的转移
-
批准号:81972762
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:朱峰
-
依托单位:
PRIMA-1met(APR-246)诱导不同状态P53基因的结直肠癌细胞自噬及其相关机制的研究
-
批准号:81603128
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:李晓岚
-
依托单位:
脂质转移蛋白基因AsE246在根瘤菌侵染和共生体发育中的共生互作机制研究
-
批准号:31371549
-
项目类别:面上项目
-
资助金额:88.0万元
-
批准年份:2013
-
负责人:李友国
-
依托单位:
紫云英根瘤中特异表达的转脂蛋白新基因AsE246的鉴定及其在共生固氮中的功能研究
-
批准号:31071346
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:陈大松
-
依托单位: